Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
295.93
-5.51 (-1.83%)
At close: Nov 14, 2024, 4:00 PM
295.21
-0.72 (-0.24%)
Pre-market: Nov 15, 2024, 6:40 AM EST
Amgen Employees
Amgen had 26,700 employees as of December 31, 2023. The number of employees increased by 1,500 or 5.95% compared to the previous year.
Employees
26,700
Change (1Y)
1,500
Growth (1Y)
5.95%
Revenue / Employee
$1,218,502
Profits / Employee
$158,427
Market Cap
159.07B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 26,700 | 1,500 | 5.95% |
Dec 31, 2022 | 25,200 | 1,000 | 4.13% |
Dec 31, 2021 | 24,200 | -100 | -0.41% |
Dec 31, 2020 | 24,300 | 900 | 3.85% |
Dec 31, 2019 | 23,400 | 1,900 | 8.84% |
Dec 31, 2018 | 21,500 | 700 | 3.37% |
Dec 31, 2017 | 20,800 | 1,600 | 8.33% |
Dec 31, 2016 | 19,200 | 1,300 | 7.26% |
Dec 31, 2015 | 17,900 | 0 | - |
Dec 31, 2014 | 17,900 | -2,100 | -10.50% |
Dec 31, 2013 | 20,000 | 2,000 | 11.11% |
Dec 31, 2012 | 18,000 | 200 | 1.12% |
Dec 31, 2011 | 17,800 | 400 | 2.30% |
Dec 31, 2010 | 17,400 | 200 | 1.16% |
Dec 31, 2009 | 17,200 | 300 | 1.78% |
Dec 31, 2008 | 16,900 | -600 | -3.43% |
Dec 31, 2007 | 17,500 | -2,600 | -12.94% |
Dec 31, 2006 | 20,100 | 3,600 | 21.82% |
Dec 31, 2005 | 16,500 | 2,100 | 14.58% |
Dec 31, 2004 | 14,400 | 1,500 | 11.63% |
Dec 31, 2003 | 12,900 | 2,800 | 27.72% |
Dec 31, 2002 | 10,100 | 2,400 | 31.17% |
Dec 31, 2001 | 7,700 | 400 | 5.48% |
Dec 31, 2000 | 7,300 | 900 | 14.06% |
Dec 31, 1999 | 6,400 | 900 | 16.36% |
Dec 31, 1998 | 5,500 | 192 | 3.62% |
Dec 31, 1997 | 5,308 | 662 | 14.25% |
Dec 31, 1996 | 4,646 | 600 | 14.83% |
Dec 31, 1995 | 4,046 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Pfizer | 88,000 |
Sanofi | 86,088 |
Danaher | 63,000 |
Boston Scientific | 48,000 |
Stryker | 26,700 |
AMGN News
- 18 hours ago - 5 Healthcare Stocks to Buy in a Beaten-Up Sector - Barrons
- 1 day ago - Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript) - Seeking Alpha
- 1 day ago - Signal Says Pharma Stock Selloff Should Be Over - Forbes
- 1 day ago - Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density - Benzinga
- 1 day ago - What's Happening With Amgen Stock? - Forbes
- 2 days ago - Amgen sees no bone safety concerns around experimental obesity drug - Reuters
- 2 days ago - AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA - PRNewsWire
- 2 days ago - Amgen stock falls as analysts mull over weight loss drug's bone density data - CNBC